Market Place
Sourcing Support
Amgen`s Biologic Repatha Receives Suppl Approval in US
20 Nov 2024 //
FDA
Amgen`s Biologic Repatha (Evolocumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Amgen 1Q Results
21 May 2024 //
CONTRACT PHARMA
U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
28 Mar 2023 //
REUTERS
Amgen-Sanofi patent case divides makers of antibody drugs
27 Mar 2023 //
REUTERS
Amgen hits back at Sanofi, Regeneron in long-running patent feud
09 Mar 2023 //
FIERCE PHARMA
Amgen To Present New Repatha® (Evolocumab) And Olpasiran Data At Acc
01 Mar 2023 //
PR NEWSWIRE
Philip Tagari switches Amgen`s discovery lab for insitro`s machine tools
02 Dec 2022 //
ENDPTS
Amgen asks Supreme Court to take up PCSK9 patent case against Sanofi & Regeneron
08 Nov 2022 //
FIERCEPHARMA
Amgen Data at ESC Show LDL-C Lowering With Repatha Was Tolerated For 8 Years
29 Aug 2022 //
PRNEWSWIRE
Amgen touts longterm Repatha data, hunts billions for PCSK9 franchise
27 Apr 2022 //
ENDPTS
SCOTUS summons help to weigh Amgen PCSK9 patent appeal
21 Apr 2022 //
FIERCEPHARMA
Supreme Court calls on top government lawyer to weigh PCSK9 patent appeal
21 Apr 2022 //
ENDPTS
Innovent Biologics` cholesterol drug IBI306 meets main goal in 2 studies
18 Feb 2022 //
SEEKING ALPHA
Amgen seeks SCOTUS review of long-running PCSK9 patent fight
30 Nov 2021 //
FIERCEPHARMA
Analyst puts Amgen`s Otezla, Repatha, biosimilars on notice
23 Nov 2021 //
FIERCEPHARMA
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
15 Nov 2021 //
BIOSPACE
Esperion to cute 170 staffers as heart disease pill sputters
19 Oct 2021 //
YAHOOFINANCE
Amgen`s Repatha gains FDA nod for genetic cholesterol disorder
28 Sep 2021 //
FIERCEPHARMA
FDA Approves Repatha In Patients Age 10 And Older
25 Sep 2021 //
PRNEWSWIRE
Amgen`s Biological Evolocumab Receives Supplemental Approval In US
24 Sep 2021 //
FDA
Repatha® Improves Features Of Plaque Stability In Patients With ACS
27 Aug 2021 //
PRNEWSWIRE
Sanofi Files Opposition to Amgen’s Petition on Praluent Patents
08 Jun 2021 //
GOODWIN
Amgen loses bid to revive patents for cholesterol drug Repatha
16 Feb 2021 //
REUTERS
Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
31 Aug 2020 //
FIERCE PHARMA
ESC: Amgen chases pediatric use for cholesterol-buster Repatha
29 Aug 2020 //
FIERCE PHARMA
Amgen Announces Positive Data From Phase 3B Study Of Repatha®
28 Aug 2020 //
PRNEWSWIRE
New Amgen Data To Be Presented At ESC Congress 2020 Highlighting Repatha®
25 Aug 2020 //
PRNEWSWIRE
Amgen`s Repatha (Evolocumab) Receives Supplemental Approval In US
14 May 2020 //
FDA
Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha®
30 Mar 2020 //
PR NEWSWIRE
Amgen`s Repatha tied to greater risk reduction in high-risk heart attack
18 Nov 2019 //
FIERCE PHARMA
Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha®
16 Nov 2019 //
PR NEWSWIRE
Amgen to phase out high price version of Repatha
25 Oct 2019 //
PHARMACEUTICAL-TECHNOLOGY
MedCo builds its case for star cholesterol RNAi therapy
25 Sep 2019 //
ENDPTS
U.S. District Court Invalidates Amgen Patents Over Cholesterol Med
30 Aug 2019 //
BIOSPACE
Amgen patents on Repatha invalid, judge rules in reversal
28 Aug 2019 //
BIOPHARMADIVE
Praluent, Repatha face major new PCSK9 threat
27 Aug 2019 //
FIERCE PHARMA
Medicines Co.`s PCSK9 drug succeeds in first Phase 3 test
27 Aug 2019 //
BIOPHARMADIVE
Regeneron preps for 2020 filing for new cholesterol drug after trial success
18 Aug 2019 //
PHARMAPHORUM
Novartis fires brother scientists alleged to be involved in data manipulation
15 Aug 2019 //
CNBC
Armed stellar if niche PhIII, Regeneron steers `breakthrough` cholesterol drug
14 Aug 2019 //
ENDPTS
AveXis top science leaders exit amid Zolgensma debacle
14 Aug 2019 //
FIERCE PHARMA
With patent win, Amgen ready to block PCSK9 rivals in Germany
13 Jul 2019 //
FIERCE PHARMA
Pharma takes Wi-Fi targeting to the doctor`s office to reach waiting patients
04 Jul 2019 //
FIERCE PHARMA
Med Co, Alnylam`s inclisiran cuts cholesterol long-term
21 May 2019 //
FIERCE BIOTECH
Repatha, Aimovig flail as cheap copies eat into Amgen sales
01 May 2019 //
FIERCE PHARMA
As Praluent Q1 sales miss Wall Street expectations, FDA expands drug’s label
30 Apr 2019 //
ENDPTS
Sanofi, Regeneron score a Praluent boost with new CV nod
29 Apr 2019 //
FIERCE PHARMA
Amgen rolls toned-down TV ad for cholesterol-fighting Repatha
23 Apr 2019 //
FIERCE PHARMA
Amgen’s Repatha (Evolocumab) Receives Supplemental Approval In US
13 Apr 2019 //
FDA
Outcomes-based Pricing Not A Panacea For High Priced Drugs
27 Mar 2019 //
FORBES
Amgen, GSK advance to #FierceMadness Elite 8
27 Mar 2019 //
FIERCE PHARMA
Sanofi gets cardio outcomes claim for Praluent in EU
18 Mar 2019 //
PM LIVE
Sanofi, Regeneron lose US patent challenge to Amgen’s cholesterol drug
27 Feb 2019 //
CNBC
Amgen`s Repatha (Evolocumab) Receives Approval in US
15 Feb 2019 //
FDA
Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
12 Feb 2019 //
REUTERS
China`s NMPA approves Amgen`s Repatha to reduce cardiovascular event risk
25 Jan 2019 //
PHARMA FILE
Amgen Receives NMPA Approval For Repatha® (evolocumab) In China
24 Jan 2019 //
PR NEWSWIRE
5 Potential Biotech M&A Targets To Watch In 2019
22 Jan 2019 //
SEEKING ALPHA
JP Morgan 2019 day two roundup – after the party a harsh reality
09 Jan 2019 //
EVALUATE
